Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1

被引：6
|
作者：
Thomas, S. [1 ,2 ]
Laino, A. [1 ,2 ]
Sturm, R. [1 ]
Nufer, K. [1 ]
Lambie, D. [2 ,3 ]
Shepherd, B. [2 ]
Atkinson, V. [4 ]
Adams, L. [1 ]
Soyer, H. P. [1 ,2 ]
Schaider, H. [1 ]
机构：
[1] Univ Queensland, Translat Res Inst, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Dept Dermatol, Brisbane, Qld, Australia
[3] IQ Pathol, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 05期
关键词：
MALIGNANT-MELANOMA; MANAGEMENT; COHORT;
D O I：
10.1111/jdv.14678
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E176 / E177
页数：2
相关论文
共 50 条
  • [41] Treatment of metastatic melanoma with anti-PD-1 and anti-LAG-3 in a kidney transplant recipient
    Patel, Janmesh D.
    Zhong, Weixiong
    Schulte, Jefree J.
    Garg, Neetika
    Birbrair, Alexander
    Pleva, Jennifer
    Ma, Vincent T.
    IMMUNOTHERAPY, 2025, 17 (03) : 179 - 184
  • [42] Dietary Fish Oil Impairs Melanoma Growth and Augments the Tumor Immune Microenvironment in Anti-PD-1 Treated Melanoma
    Chacon, Alexander C.
    Qin, Shuyang S.
    Melucci, Alexa D.
    Jackson, Katherine M.
    Ullman, Nicholas A.
    Burchard, Paul R.
    Dave, Yatee A.
    Jewell, Rachel
    Belt, Brian
    Tabayoyong, William
    Prieto, Peter A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S59 - S59
  • [43] Differences in immune profiles of metastatic melanoma patients treated with anti-CTLA-4 and anti-PD-1 combined immunotherapy.
    Gide, Tuba Nur
    Quek, Camelia
    Madore, Jason
    Menzies, Alexander M.
    Dent, Rebecca
    Carlino, Matteo S.
    Guminski, Alex
    Saw, Robyn
    Thompson, John F.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [44] A case of primary malignant melanoma of the lung responded to anti-PD-1 antibody therapy
    Hirai I.
    Tanese K.
    Obata S.
    Funakoshi T.
    Indian Journal of Thoracic and Cardiovascular Surgery, 2017, 33 (2) : 173 - 175
  • [45] Partial Remission of metastatic Melanoma after a single Gift of the anti-PD-1 Antibody Pembrolizumab
    Schilling, B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 12 - 12
  • [46] Excellent response to anti-PD-1 therapy in a patient with metastatic malignant melanoma: case report
    Silvestri, Antonia
    Specchia, Monica
    Musacchio, Michela
    Giglio, Gianfranco
    Carrozza, Francesco
    Di Lullo, Liberato
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [47] INVESTIGATION OF WNT LIGAND SIGNALING REGULATORS AS A PREDICTOR OF ANTI-PD-1 RESPONSE IN METASTATIC MELANOMA
    DeVito, Nicholas
    Sturdivant, Michael
    Wachsmuth, Luke
    Strickler, John
    Beasley, Georgia
    Al-Rohil, Rami
    Salama, April
    Hanks, Brent
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A258 - A259
  • [48] Anti-PD-1 induced collagenous colitis in metastatic melanoma: a rare severe adverse event
    Janela-Lapert, Raphael
    Bouteiller, Julie
    Deschamps-Huvier, Aurelie
    Duval-Modeste, Anne-Benedicte
    Joly, Pascal
    MELANOMA RESEARCH, 2020, 30 (06) : 603 - 605
  • [49] FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma
    Tan, A. C.
    Emmett, L.
    Lo, S.
    Liu, V.
    Kapoor, R.
    Carlino, M. S.
    Guminski, A. D.
    Long, G. V.
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2115 - 2120
  • [50] Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma
    Lee, Jenny H. J.
    Lyle, Megan
    Menzies, Alexander M.
    Chan, Matthew M. K.
    Lo, Serigne
    Clements, Arthur
    Carlino, Matteo S.
    Kefford, Richard F.
    Long, Georgina, V
    PIGMENT CELL & MELANOMA RESEARCH, 2018, 31 (03) : 404 - 410
12345